WeChats
08-31

A-Shares Rebound ⚡ Moutai vs Cambricon — Who Really Leads China’s Market?


Chinese equities finally showed signs of life this week. The ChiNext Index climbed back above 2,900, while both Shanghai and Shenzhen closed higher. But beneath the relief rally is a bigger narrative: the battle between old economy champions like Kweichow Moutai (600519.SH) and new economy hopefuls like Cambricon (688256.SH).

This is not just a numbers game — it’s a question of where the soul of China’s equity market lies: in the steady strength of traditional brands, or in the moonshot dreams of AI and tech.

---

🍶 Moutai: The Liquor King That Refuses to Fade

Moutai is more than a stock. It’s a cultural institution, a “safe haven” within A-shares. Even with valuations looking rich, the brand still commands:

Pricing power: Bottles of Moutai still change hands at premiums, even in downturns.

Earnings resilience: Despite macro weakness, margins stay intact.

Investor psychology: To many, Moutai is the A-share market — dependable, prestigious, and liquid (literally and figuratively).

But here’s the catch: while Moutai remains a fortress, its growth engine is slowing. Investors are starting to ask whether paying top dollar for stability alone makes sense. Has Moutai become more of a “bond proxy” than a growth play?

---

🤖 Cambricon: The AI Hope With Fragile Wings

On the other side stands Cambricon, once hyped as China’s NVIDIA. Its story embodies Beijing’s push for semiconductor self-sufficiency. Yet the road has been bumpy:

Stock swings: Cambricon’s recent sharp drop underscores how quickly AI hype can deflate.

Competition: Huawei’s Ascend chips and other domestic entrants eat away at its edge.

Execution risk: Scaling AI chips to profitability is far harder than promising them.

Still, the AI megatrend is undeniable. From autonomous driving to generative AI, demand is set to explode. If Cambricon can capture even part of this wave, its growth could dwarf consumer staples. But that’s a big if.

---

⚖️ Old Economy vs New Economy — Who Wins the Next Decade?

This rivalry is symbolic of China’s broader equity dilemma. Do you back:

The proven cash flows of consumer staples like Moutai, where downside risk is limited but upside capped?

The innovation lottery of companies like Cambricon, where success could be explosive, but failure equally spectacular?

For now, Moutai’s dominance remains unshaken. But history shows: every “old king” eventually meets a challenger strong enough to rewrite the story. Could AI and chips be that challenger for A-shares?

---

💡 Investor Lens: How to Play This Tug-of-War

For Tiger investors, this isn’t about picking sides blindly. It’s about portfolio balance and timing:

In volatile markets, staples like Moutai provide ballast.

In growth phases, tech names like Cambricon can turbocharge returns.

Risk management: Keep positions sized right. Betting too heavily on AI hype can wipe out gains; ignoring it altogether could leave you behind.

👉 The smartest investors often hold both — letting the “old king” defend the base, while the “new challenger” provides upside optionality.

---

🔮 The Bigger Question for A-Shares

China’s markets are regaining momentum, but leadership is up for grabs. Will the next decade be defined by heritage and tradition, or innovation and disruption? The answer may shape not just portfolios, but the global perception of China’s equity story.

---

🤔 What Do You Think, Tigers?

Would you rather hold the stability of Moutai or the growth promise of Cambricon?

Is Moutai still the undisputed “king of A-shares,” or is it past its prime?

Can China’s tech upstarts ever match the cultural and financial dominance of traditional giants?

@TigerStars  @Tiger_comments  @Daily_Discussion  @TigerEvents  @TigerWire  

China Stocks Are Surging: Do You Know These HK SDRs?
Global stock markets keep hitting new highs — except China. But things may be changing. Xtrackers Harvest CSI 300 China A-Shares ETF is already up +19.95% YTD, beating $Invesco QQQ(QQQ)$’s +10.64%. So what’s the easiest way for SG investors to get exposure? Besides directly buying HK-listed Chinese companies, you can also buy SDRs (Singapore Depository Receipts), which track popular HK stocks one-for-one or at set ratios. 1. Would you buy China exposure through HK stocks directly, or SDRs listed in SG? 2. If you’re bullish long-term, would you go as far as buying LEAP calls on HK names?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1